These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 8594072)
1. CD44v6 is a marker for systemic spread in cutaneous T-cell lymphomas. A comparative study between nodal and cutaneous lymphomas. Dommann SN; Ziegler T; Dommann-Schener CC; Meyer J; Panizzon R; Burg G J Cutan Pathol; 1995 Oct; 22(5):407-12. PubMed ID: 8594072 [TBL] [Abstract][Full Text] [Related]
2. Expression of intercellular adhesion molecule 3 (CDw50) on endothelial cells in cutaneous lymphomas. A comparative study between nodal and cutaneous lymphomas. Dommann SN; Dommann-Scherrer CC; Ziegler T; Meyer J; Trüeb RM; Kündig T; Panizzon R; Burg G Am J Dermatopathol; 1997 Aug; 19(4):391-5. PubMed ID: 9261475 [TBL] [Abstract][Full Text] [Related]
3. CD44 variant expression in cutaneous T-cell lymphoma. Orteu CH; Li W; Allen MH; Smith NP; Barker JN; Whittaker SJ J Cutan Pathol; 1997 Jul; 24(6):342-9. PubMed ID: 9243361 [TBL] [Abstract][Full Text] [Related]
4. Expression of CD44 and CD44v6 in primary cutaneous CD30 positive T-cell lymphoproliferative disorders. Liang X; Smoller BR; Golitz LE J Cutan Pathol; 2002 Sep; 29(8):459-64. PubMed ID: 12207739 [TBL] [Abstract][Full Text] [Related]
5. CD44v6 expression in non-Hodgkin's lymphoma: an association with low histological grade and poor prognosis. Ristamäki R; Joensuu H; Söderström KO; Jalkanen S J Pathol; 1995 Jul; 176(3):259-67. PubMed ID: 7545748 [TBL] [Abstract][Full Text] [Related]
6. The prognostic value of adhesion molecule CD44v6 in women with primary breast carcinoma: a clinicopathologic study. Ma W; Deng Y; Zhou L Clin Oncol (R Coll Radiol); 2005 Jun; 17(4):258-63. PubMed ID: 15997921 [TBL] [Abstract][Full Text] [Related]
7. Association of expression of CD44v6 with systemic anaplastic large cell lymphoma: comparison with primary cutaneous anaplastic large cell lymphoma. Liang X; Golitz LE; Smoller BR; Meech SJ; Odom LF; Williams SA; Ryder JW Am J Clin Pathol; 2002 Feb; 117(2):276-82. PubMed ID: 11863224 [TBL] [Abstract][Full Text] [Related]
8. Expression of the human peripheral lymph node homing receptor (LECAM-1) in nodal and gastrointestinal non-Hodgkin's lymphomas. Pals ST; Meijer CJ; Radaszkiewicz T Leukemia; 1991 Jul; 5(7):628-31. PubMed ID: 2072751 [TBL] [Abstract][Full Text] [Related]
9. Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's disease. Kanavaros P; Vlychou M; Stefanaki K; Rontogianni D; Gaulard P; Pantelidaki E; Zois M; Darivianaki K; Georgoulias V; Boulland ML; Gorgoulis V; Kittas C Anticancer Res; 1999; 19(2A):1209-16. PubMed ID: 10368677 [TBL] [Abstract][Full Text] [Related]
10. CD44V6 expression in human colorectal carcinoma. Coppola D; Hyacinthe M; Fu L; Cantor AB; Karl R; Marcet J; Cooper DL; Nicosia SV; Cooper HS Hum Pathol; 1998 Jun; 29(6):627-35. PubMed ID: 9635685 [TBL] [Abstract][Full Text] [Related]
12. CD44 variant exons in leukemia and lymphoma. Akisik E; Bavbek S; Dalay N Pathol Oncol Res; 2002; 8(1):36-40. PubMed ID: 11994761 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of CD44 and CD44v6 in colorectal carcinoma patients: soluble forms in relation to tumor tissue expression and metastasis. Amirghofran Z; Jalali SA; Hosseini SV; Vasei M; Sabayan B; Ghaderi A J Gastrointest Cancer; 2008; 39(1-4):73-8. PubMed ID: 19333790 [TBL] [Abstract][Full Text] [Related]
14. CD44v6-competent tumor exosomes promote motility, invasion and cancer-initiating cell marker expression in pancreatic and colorectal cancer cells. Wang Z; von Au A; Schnölzer M; Hackert T; Zöller M Oncotarget; 2016 Aug; 7(34):55409-55436. PubMed ID: 27419629 [TBL] [Abstract][Full Text] [Related]
15. CD44v6 expression in primary breast carcinoma in western India: a pilot clinicopathologic study. Shah NG; Trivedi TI; Vora HH; Patel KC; Tankshali R; Goswami JV; Shukla SN; Shah PM Tumori; 2010; 96(6):971-7. PubMed ID: 21388061 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of immunohistochemically detected CD44 isoforms CD44v5, CD44v6 and CD44v7-8 in human breast cancer. Tempfer C; Lösch A; Heinzl H; Häusler G; Hanzal E; Kölbl H; Breitenecker G; Kainz C Eur J Cancer; 1996 Oct; 32A(11):2023-5. PubMed ID: 8943691 [TBL] [Abstract][Full Text] [Related]
17. CD44 exon v6 correlates with cellular differentiation but not with progression and metastasis of cervical cancer. Tokumo K; Kodama J; Seki N; Miyagi Y; Yoshinouchi M; Kudo T Eur J Cancer; 1998 Dec; 34(13):2107-11. PubMed ID: 10070319 [TBL] [Abstract][Full Text] [Related]
18. Clinicopathological associations of CD44 mRNA and protein expression in primary breast carcinomas. Berner HS; Suo Z; Risberg B; Villman K; Karlsson MG; Nesland JM Histopathology; 2003 Jun; 42(6):546-54. PubMed ID: 12786890 [TBL] [Abstract][Full Text] [Related]
19. [Adhesion molecules in dermato-oncology]. Dommann SN Hautarzt; 1996 Mar; 47(3):169-71. PubMed ID: 8647697 [TBL] [Abstract][Full Text] [Related]
20. Clonal disease in extracutaneous compartments in cutaneous T-cell lymphomas. A comparative study between cutaneous T-cell lymphomas and pseudo lymphomas. Dommann SN; Dommann-Scherrer CC; Dours-Zimmermann MT; Zimmermann DR; Kural-Serbes B; Burg G Arch Dermatol Res; 1996 Apr; 288(4):163-7. PubMed ID: 8967786 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]